Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene-Reference-Cited by-同舟云学术

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

Published:2010-04-18 Issue:5 Volume:42 Page:410-414
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Meindl Alfons,Hellebrand Heide,Wiek Constanze,Erven Verena,Wappenschmidt Barbara,Niederacher Dieter,Freund Marcel,Lichtner Peter,Hartmann Linda,Schaal Heiner,Ramser Juliane,Honisch Ellen,Kubisch Christian,Wichmann Hans E,Kast Karin,Deißler Helmut,Engel Christoph,Müller-Myhsok Bertram,Neveling Kornelia,Kiechle Marion,Mathew Christopher G,Schindler Detlev,Schmutzler Rita K,Hanenberg Helmut

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.569.pdf

Reference35 articles.

1. Turnbull, C. & Rahman, N. Genetic predisposition to breast cancer: past, present, and future. Annu. Rev. Genomics Hum. Genet. 9, 321–345 (2008).

2. Ciccia, A., McDonald, N. & West, S.C. Structural and functional relationships of the XPF/MUS81 family of proteins. Annu. Rev. Biochem. 77, 259–287 (2008).

3. Wang, W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat. Rev. Genet. 8, 735–748 (2007).

4. Neveling, K., Endt, D., Hoehn, H. & Schindler, D. Genotype-phenotype correlations in Fanconi anemia. Mutat. Res. 668, 73–91 (2009).

5. Vaz, F. et al. Mutation of the RAD51C gene in Fanconi anemia. Nat. Genet. advance online publication, doi:10.1038/ng.570 (18 April 2010).

Cited by 612 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients with hereditary gastric cancer linked to a family history of hereditary breast and ovarian cancer (HBOC);2024-09-05

2. Prevention of Ovarian Cancer: Where are We Now and Where are We Going?;Current Oncology Reports;2024-08-08

3. FANCM branchpoint translocase: Master of traverse, reverse and adverse DNA repair;DNA Repair;2024-08

4. BRCAness, DNA gaps, and gain and loss of PARP inhibitor–induced synthetic lethality;Journal of Clinical Investigation;2024-07-15

5. Is the Homologous Recombination Repair Mutation Defined by a 15-Gene Panel Associated with the Prognosis of Epithelial Ovarian Cancer?;Molecular Diagnosis & Therapy;2024-07-05